EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 352 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2020. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $97,365 | -47.7% | 13,247 | -26.3% | 0.00% | -50.0% |
| Q1 2023 | $186,314 | -74.3% | 17,984 | -70.7% | 0.00% | -66.7% |
| Q4 2022 | $724,319 | -12.7% | 61,331 | +55.1% | 0.01% | -25.0% |
| Q3 2022 | $830,000 | -35.2% | 39,546 | -4.1% | 0.01% | -20.0% |
| Q2 2022 | $1,280,000 | -63.7% | 41,219 | -52.0% | 0.01% | -52.4% |
| Q1 2022 | $3,522,000 | -4.8% | 85,792 | +0.8% | 0.02% | +10.5% |
| Q4 2021 | $3,700,000 | -48.9% | 85,112 | -41.2% | 0.02% | -56.8% |
| Q3 2021 | $7,247,000 | -24.3% | 144,741 | -4.7% | 0.04% | -21.4% |
| Q2 2021 | $9,571,000 | -30.4% | 151,942 | +2.6% | 0.06% | -37.8% |
| Q1 2021 | $13,753,000 | +4.7% | 148,031 | +1.0% | 0.09% | +9.8% |
| Q4 2020 | $13,134,000 | +24.7% | 146,585 | +43.8% | 0.08% | +7.9% |
| Q3 2020 | $10,531,000 | +3.5% | 101,912 | -20.8% | 0.08% | -3.8% |
| Q2 2020 | $10,174,000 | +36.4% | 128,656 | -0.2% | 0.08% | +5.3% |
| Q1 2020 | $7,461,000 | +7.0% | 128,945 | -0.2% | 0.08% | +44.2% |
| Q4 2019 | $6,971,000 | +5.3% | 129,195 | +2.0% | 0.05% | -1.9% |
| Q3 2019 | $6,620,000 | +14.2% | 126,629 | +5.5% | 0.05% | +12.8% |
| Q2 2019 | $5,797,000 | +2.5% | 120,004 | +7.2% | 0.05% | +2.2% |
| Q1 2019 | $5,657,000 | -23.0% | 111,967 | -9.6% | 0.05% | -25.8% |
| Q4 2018 | $7,344,000 | -18.5% | 123,892 | -9.5% | 0.06% | +5.1% |
| Q3 2018 | $9,010,000 | -19.4% | 136,871 | -38.2% | 0.06% | -21.3% |
| Q2 2018 | $11,182,000 | -22.0% | 221,454 | -18.7% | 0.08% | +114.3% |
| Q1 2018 | $14,336,000 | -9.0% | 272,283 | -19.7% | 0.04% | -5.4% |
| Q4 2017 | $15,751,000 | +6.9% | 338,918 | -7.0% | 0.04% | +5.7% |
| Q3 2017 | $14,734,000 | +19.3% | 364,277 | -0.0% | 0.04% | +6.1% |
| Q2 2017 | $12,355,000 | +10.6% | 364,399 | -5.2% | 0.03% | +10.0% |
| Q1 2017 | $11,168,000 | -12.4% | 384,577 | -1.0% | 0.03% | -16.7% |
| Q4 2016 | $12,754,000 | -23.8% | 388,390 | -26.9% | 0.04% | -30.8% |
| Q3 2016 | $16,748,000 | +14.7% | 531,206 | +2.3% | 0.05% | +13.0% |
| Q2 2016 | $14,599,000 | -22.3% | 519,169 | +0.5% | 0.05% | -22.0% |
| Q1 2016 | $18,785,000 | -11.6% | 516,784 | -2.7% | 0.06% | -4.8% |
| Q4 2015 | $21,245,000 | +50.8% | 530,957 | +7.4% | 0.06% | +44.2% |
| Q3 2015 | $14,088,000 | -31.1% | 494,493 | -20.3% | 0.04% | -14.0% |
| Q2 2015 | $20,436,000 | -0.7% | 620,188 | -13.3% | 0.05% | +2.0% |
| Q1 2015 | $20,584,000 | +0.1% | 715,716 | -5.3% | 0.05% | -5.8% |
| Q4 2014 | $20,573,000 | +26.6% | 755,502 | -0.9% | 0.05% | +33.3% |
| Q3 2014 | $16,244,000 | +97.4% | 762,310 | +108.1% | 0.04% | +85.7% |
| Q2 2014 | $8,228,000 | +147.2% | 366,309 | +178.2% | 0.02% | +133.3% |
| Q1 2014 | $3,328,000 | +11.8% | 131,662 | +1.7% | 0.01% | 0.0% |
| Q4 2013 | $2,976,000 | +20.4% | 129,438 | -0.2% | 0.01% | 0.0% |
| Q3 2013 | $2,471,000 | +36.2% | 129,712 | +3.1% | 0.01% | +12.5% |
| Q2 2013 | $1,814,000 | – | 125,820 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Laurus Investment Counsel Inc. | 120,504 | $10,797,000 | 4.20% |
| SNYDER CAPITAL MANAGEMENT L P | 723,477 | $64,824,000 | 2.12% |
| Hillcrest Asset Management LLC | 161,428 | $14,464,000 | 1.97% |
| RICE HALL JAMES & ASSOCIATES, LLC | 587,727 | $52,660,000 | 1.85% |
| PALISADE CAPITAL MANAGEMENT, LP | 579,009 | $51,879,000 | 1.33% |
| Pier Capital, LLC | 109,786 | $9,837,000 | 1.04% |
| Paradiem, LLC | 21,320 | $2,286,000 | 0.97% |
| EARNEST PARTNERS LLC | 1,390,735 | $124,610,000 | 0.86% |
| Ridgewood Investments LLC | 10,004 | $1,034,000 | 0.82% |
| Tygh Capital Management, Inc. | 56,334 | $5,048,000 | 0.78% |